Toll-like receptor-4 mediated inflammation is involved in the cardiometabolic alterations induced by intermittent hypoxia

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Poulain, Laureline ^a,b   Richard, Vincent ^c,d   Lévy, Patrick ^a,b,e   Dematteis, Maurice ^a,b,e   Arnaud, Claire ^a,b  

^a UNIV GRENOBLE ALPES   (France)

^b University Grenoble Alpes   (France)

^c UNIVERSITÉ DE ROUEN   (France)

^d Université Normandie de Rouen   (France)

^e HÔPITAL MICHALLON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TLR4 PROTEIN, MOUSE;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; EPIDIDYMIS FAT; INFLAMMATION; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; INTERMITTENT HYPOXIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THORACIC AORTA; VASCULAR REMODELING; VASCULITIS; ADIPOSE TISSUE; ANIMAL; AORTA; C57BL MOUSE; COMPLICATION; HYPOXIA; KNOCKOUT MOUSE; PATHOLOGY; PHYSIOLOGY;

ANIMALIA; MUS;

ADIPOSE TISSUE; ANIMALS; AORTA; HYPOXIA; INFLAMMATION; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; VASCULAR REMODELING;

EID: 84926345483     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/620258     Document Type: Article

References (57)

1. V. K. Somers, D. P. White, R. Amin et al., "Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement fromthe American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health), " Circulation, vol. 118, no. 10, pp. 1080-1111, 2008.
2. N. M. Punjabi, E. Shahar, S. Redline, D. J. Gottlieb, R. Givelber, and H. E. Resnick, "Sleep-disordered breathing, glucose intolerance, and insulin resistance: the sleep heart health study, " The American Journal of Epidemiology, vol. 160, no. 6, pp. 521-530, 2004.
3. K. J. Reichmuth, D. Austin, J. B. Skatrud, and T. Young, "Association of sleep apnea and type II diabetes: a population-based study, " The American Journal of Respiratory and Critical Care Medicine, vol. 172, no. 12, pp. 1590-1595, 2005.
4. J.-P. Baguet, L. Hammer, P. Levy et al., "The severity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence, " Chest, vol. 128, no. 5, pp. 3407-3412, 2005.
5. L. F. Drager, L. A. Bortolotto, M. C. Lorenzi, A. C. Figueiredo, E. M. Krieger, andG. Lorenzi-Filho, "Early signs of atherosclerosis in obstructive sleep apnea, " The American Journal of Respiratory and Critical Care Medicine, vol. 172, no. 5, pp. 613-618, 2005.
6. B. D. Kent, J. F. Garvey, S. Ryan, G. Nolan, J. D. Dodd, andW. T. McNicholas, "Severity of obstructive sleep apnoea predicts coronary artery plaque burden: a coronary computed tomographic angiography study, " European Respiratory Journal, vol. 42, no. 5, pp. 1263-1270, 2013.
7. M. Dematteis, D. Godin-Ribuot, C. Arnaud et al., "Cardiovascular consequences of sleep-disordered breathing: contribution of animal models to understanding of the human disease, " ILAR Journal, vol. 50, no. 3, pp. 262-281, 2009.
8. J. Jun and V. Y. Polotsky, "Metabolic consequences of sleep-disordered breathing, " ILAR Journal, vol. 50, no. 3, pp. 289-306, 2009.
9. N. L. Kanagy, "Vascular effects of intermittent hypoxia, " ILAR Journal, vol. 50, no. 3, pp. 282-288, 2009.
10. L. Poulain, A. Thomas, J. Rieusset et al., "Visceral white fat remodelling contributes to intermittent hypoxia-induced atherogenesis, " European Respiratory Journal, vol. 43, no. 2, pp. 513-522, 2014.
11. C. N. Lumeng and A. R. Saltiel, "Inflammatory links between obesity and metabolic disease, " Journal of Clinical Investigation, vol. 121, no. 6, pp. 2111-2117, 2011.
12. G. R. Hajer, T. W. Van Haeften, and F. L. J. Visseren, "Adipose tissue dysfunction in obesity, diabetes, and vascular diseases, " European Heart Journal, vol. 29, no. 24, pp. 2959-2971, 2008.
13. R. Medzhitov, "Toll-like receptors and innate immunity, " Nature Reviews Immunology, vol. 1, no. 2, pp. 135-145, 2001.
14. Q. Li and I. M. Verma, "NF-βB regulation in the immune system, " Nature Reviews Immunology, vol. 2, no. 10, pp. 725-734, 2002.
15. F. Kim, M. Pham, I. Luttrell et al., "Toll-like receptor-4mediates vascular inflammation and insulin resistance in diet-induced obesity, " Circulation Research, vol. 100, no. 11, pp. 1589-1596, 2007.
16. K. S. Michelsen, M. H. Wong, P. K. Shah et al., "Lack of tolllike receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E, " Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 29, pp. 10679-10684, 2004.
17. C. Arnaud, P. C. Beguin, S. Lantuejoul et al., "The inflammatory preatherosclerotic remodeling induced by intermittent hypoxia is attenuated by RANTES/CCL5 inhibition, " The American Journal of Respiratory and Critical Care Medicine, vol. 184, no. 6, pp. 724-731, 2011.
18. M. Dematteis, C. Julien, C. Guillermet et al., "Intermittent hypoxia induces early functional cardiovascular remodeling in mice, " The American Journal of Respiratory and Critical Care Medicine, vol. 177, no. 2, pp. 227-235, 2008.
19. L. F. Drager, J. Li, C. Reinke, S. Bevans-Fonti, J. C. Jun, and V. Y. Polotsky, "Intermittent hypoxia exacerbatesmetabolic effects of diet-induced obesity, " Obesity, vol. 19, no. 11, pp. 2167-2174, 2011.
20. J. Li, M. Bosch-Marce, A. Nanayakkara et al., "Alteredmetabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor-1, " Physiological Genomics, vol. 25, no. 3, pp. 450-457, 2006.
21. J. Jun, C. Reinke, D. Bedja et al., "Effect of intermittent hypoxia on atherosclerosis in apolipoprotein E-deficient mice, " Atherosclerosis, vol. 209, no. 2, pp. 381-386, 2010.
22. A. Barcelo, J. Pierola, M. De La Pena et al., "Free fatty acids and the metabolic syndrome in patients with obstructive sleep apnoea, " European Respiratory Journal, vol. 37, no. 6, pp. 1418-1423, 2011.
23. D. Langin, "Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome, " Pharmacological Research, vol. 53, no. 6, pp. 482-491, 2006.
24. V. K. Somers, M. E. Dyken, M. P. Clary, and F. M. Abboud, "Sympathetic neural mechanisms in obstructive sleep apnea, " Journal of Clinical Investigation, vol. 96, no. 4, pp. 1897-1904, 1995.
25. L. Zu, H. Jiang, J. He et al., "Salicylate blocks lipolytic actions of tumor necrosis factor-β in primary rat adipocytes, " Molecular Pharmacology, vol. 73, no. 1, pp. 215-223, 2008.
26. Q. He, Q. C. Yang, Q. Zhou et al., "Effects of varying degrees of intermittent hypoxia on proinflammatory cytokines and adipokines in rats and 3T3-L1 adipocytes, " PLoS ONE, vol. 9, no. 1, Article ID e86326, 2014.
27. C. Reinke, S. Bevans-Fonti, L. F. Drager, M.-K. Shin, and V. Y. Polotsky, "Effects of different acute hypoxic regimens on tissue oxygen profiles and metabolic outcomes, " Journal of Applied Physiology, vol. 111, no. 3, pp. 881-890, 2011.
28. P. Trayhurn, B. Wang, and I. S. Wood, "Hypoxia and the endocrine and signalling role of white adipose tissue, " Archives of Physiology and Biochemistry, vol. 114, no. 4, pp. 267-276, 2008.
29. D. Tripathy, P. Mohanty, S. Dhindsa et al., "Elevationof free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects, " Diabetes, vol. 52, no. 12, pp. 2882-2887, 2003.
30. H. Shi, M. V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J. S. Flier, "TLR4 links innate immunity and fatty acid-induced insulin resistance, " Journal of Clinical Investigation, vol. 116, no. 11, pp. 3015-3025, 2006.
31. T. Suganami, T. Mieda, M. Itoh, Y. Shimoda, Y. Kamei, and Y. Ogawa, "Attenuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a Toll-like receptor 4 mutation, " Biochemical and Biophysical Research Communications, vol. 354, no. 1, pp. 45-49, 2007.
32. D. M. L. Tsukumo, M. A. Carvalho-Filho, J. B. C. Carvalheira et al., "Loss-of-function mutation in toll-like receptor 4 prevents diet-induced obesity and insulin resistance, " Diabetes, vol. 56, no. 8, pp. 1986-1998, 2007.
33. L. Zu, J. He, H. Jiang, C. Xu, S. Pu, and G. Xu, "Bacterial endotoxin stimulates adipose lipolysis via toll-like receptor 4 and extracellular signal-regulated kinase pathway, " The Journal of Biological Chemistry, vol. 284, no. 9, pp. 5915-5926, 2009.
34. M. Franchini, E. Monnais, D. Seboek et al., "Insulin resistance and increased lipolysis in bone marrow derived adipocytes stimulated with agonists of toll-like receptors, " Hormone and Metabolic Research, vol. 42, no. 10, pp. 703-709, 2010.
35. V. Y. Polotsky, J. Li, N. M. Punjabi et al., "Intermittent hypoxia increases insulin resistance in genetically obese mice, " Journal of Physiology, vol. 552, no. 1, pp. 253-264, 2003.
36. N. Iiyori, L. C. Alonso, J. Li et al., "Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity, " American Journal of Respiratory and Critical Care Medicine, vol. 175, no. 8, pp. 851-857, 2007.
37. P. Priou, T. Pigeanne, M. Le Vaillant et al., "Independent association between obstructive sleep apnea severity and glycated hemoglobin in adults without diabetes, " Diabetes Care, vol. 35, no. 9, pp. 1902-1906, 2012.
38. S. Pamidi, K. Wroblewski, J. Broussard et al., "Obstructive sleep apnea in young lean men: Impacton insulin sensitivity and secretion, " Diabetes Care, vol. 35, no. 11, pp. 2384-2389, 2012.
39. A.-L. Borel, D. Monneret, R. Tamisier et al., "The severity of nocturnal hypoxia but not abdominal adiposity is associated with insulin resistance in non-obese men with sleep apnea, " PLoS ONE, vol. 8, no. 8, Article ID e71000, 2013.
40. M. Louis and N. M. Punjabi, "Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers, " Journal of Applied Physiology, vol. 106, no. 5, pp. 1538-1544, 2009.
41. G. Boden, F. Jadali, J. White et al., "Effects of fat on insulinstimulated carbohydrate metabolism in normal men, " Journal of Clinical Investigation, vol. 88, no. 3, pp. 960-966, 1991.
42. E. Park, V. Wong, X. Guan, A. I. Oprescu, and A. Giacca, "Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo, " Journal of Endocrinology, vol. 195, no. 2, pp. 323-331, 2007.
43. G. S. Hotamisligil, N. S. Shargill, and B. M. Spiegelman, "Adipose expression of tumor necrosis factor-β: direct role in obesity-linked insulin resistance, " Science, vol. 259, no. 5091, pp. 87-91, 1993.
44. V. Savransky, A. Nanayakkara, J. Li et al., "Chronic intermittent hypoxia induces atherosclerosis, " The American Journal of Respiratory and Critical CareMedicine, vol. 175, no. 12, pp. 1290-1297, 2007.
45. C. Arnaud, L. Poulain, P. Levy, and M. Dematteis, "Inflammation contributes to the atherogenic role of intermittent hypoxia in apolipoprotein-E knock out mice, " Atherosclerosis, vol. 219, no. 2, pp. 425-431, 2011.
46. C. K. Glass and J. M. Olefsky, "Inflammation and lipid signaling in the etiology of insulin resistance, " CellMetabolism, vol. 15, no. 5, pp. 635-645, 2012.
47. G. Fantuzzi and T. Mazzone, "Adipose tissue and atherosclerosis: Exploring the connection, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 5, pp. 996-1003, 2007.
48. G. Fang, D. Song, X. Ye, S.-Z. Mao, G. Liu, andS. F. Liu, "Chronic intermittent hypoxia exposure induces atherosclerosis in ApoE knockout mice: role of NF-βB p50, " The American Journal of Pathology, vol. 181, no. 5, pp. 1530-1539, 2012.
49. E. Gautier-Veyret, C. Arnaud, M. Back et al., "Intermittent hypoxia-activated cyclooxygenase pathway: role in atherosclerosis, " European Respiratory Journal, vol. 42, no. 2, pp. 404-413, 2013.
50. D. Song, G. Fang, S. Z. Mao et al., "Chronic intermittent hypoxia induces atherosclerosis by NF-βB-dependent mechanisms, " Biochimica et Biophysica Acta, vol. 1822, no. 11, pp. 1650-1659, 2012.
51. P. R. de Batista, R. Palacios, A. Martin et al., "Toll-like receptor upregulation by angiotensin II contributes to hypertension and vascular dysfunction through reactive oxygen species production, " PLoS ONE, vol. 9, no. 8, Article ID e104020, 2014.
52. D. Sollinger, R. Eiler, S. Lorenz et al., "Damage-associated molecular pattern activated Toll-like receptor 4 signalling modulates blood pressure in l-NAME-induced hypertension, " Cardiovascular Research, vol. 101, no. 3, pp. 464-472, 2014.
53. K. Edfeldt, J. Swedenborg, G. K. Hansson, and Z. Q. Yan, "Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation, " Circulation, vol. 105, no. 10, pp. 1158-1161, 2002.
54. X. H. Xu, P. K. Shah, E. Faure et al., "Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL, " Circulation, vol. 104, no. 25, pp. 3103-3108, 2001.
55. H. Bjorkbacka, V. V. Kunjathoor, K. J. Moore et al., "Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways, " Nature Medicine, vol. 10, no. 4, pp. 416-421, 2004.
56. Y. Ding, S. Subramanian, V. N. Montes et al., "Toll-like receptor deficiency decreases atherosclerosis but does not protect against inflammation in obese low-density lipoprotein receptordeficient mice., " Arteriosclerosis, thrombosis, and vascular biology, vol. 32, no. 7, pp. 1596-1604, 2012.
57. M. Akinnusi, P. Jaoude, T. Kufel, and A. A. El-Solh, "Toll-like receptor activity in patients with obstructive sleep apnea, " Sleep and Breathing, vol. 17, no. 3, pp. 1009-1016, 2013.